Laddar...
Histone deacetylase inhibitors: molecular mechanisms of action and clinical trials as anti-cancer drugs
Histone deacetylase (HDAC) inhibitors are a relatively new class of anti-cancer agents that play important roles in epigenetic or non-epigenetic regulation, inducing death, apoptosis, and cell cycle arrest in cancer cells. Recently, their use has been clinically validated in cancer patients resultin...
Sparad:
| Huvudupphovsmän: | , |
|---|---|
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
e-Century Publishing Corporation
2010
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3056563/ https://ncbi.nlm.nih.gov/pubmed/21416059 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|